Ranbaxy Nexium Generic Still Not Launched Despite Approval
This article was originally published in PharmAsia News
Executive Summary
Five months on, Ranbaxy Laboratories’ generic version of AstraZeneca's best-selling gastrointestinal drug Nexium (esomeprazole) remains off the market during its six months of marketing exclusivity.